Indivior reported 0.54 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.

Fiscal Calendar Actual Consensus Previous Date
FY2025Q1 Mar/2025 0.37 0.37 Apr/24 2025
FY2024Q4 Dec/2024 0.26 0.43 Feb/13 2025
FY2024Q3 Sep/2024 0.54 0.407 Oct/23 2024
FY2024Q2 Jun/2024 0.44 0.44 Jul/24 2024
FY2024Q1 Mar/2024 0.37 0.37 Apr/24 2024
FY2023Q4 Dec/2023 0.43 0.43 Feb/21 2024
FY2023Q3 Sep/2023 0.34 0.34 Nov/08 2023
FY2023Q2 Jun/2023 0.39 0.39 Jul/26 2023
FY2023Q1 Mar/2023 0.4 0.4 Apr/26 2023
Sep/2022 0.29 0.29 Oct/26 2022

Eps Change Date
AstraZeneca USD 2.08 0.1 Sep/2024
Eli Lilly USD 1.18 2.74 Sep/2024
Glaxosmithkline USD -0.01 1.11 Sep/2024
Halozyme Therapeutics USD 1.27 0.36 Sep/2024
Indivior 0.54 0.1 Sep/2024
J&J USD 2.04 0.63 Dec/2024
Kyowa Hakko Kirin JPY 34.44 9.06 Sep/2024
Merck USD 1.57 0.71 Sep/2024
Novartis USD 1.57 0.4 Sep/2024
Pfizer USD 1.06 0.46 Sep/2024
Sanofi USD 1.57 0.64 Sep/2024
Supernus Pharmaceuticals USD 0.69 0.33 Sep/2024